Anthony F. Goncalves
Marseille, 13009, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 279 publications
ESR1 Y537S Detected in a Brain Metastasis but Not in Plasma ctDNA in HR+/HER2-Low Metastatic Breast Cancer: A Case Report.
Journal: Current oncology (Toronto, Ont.)
Published: June 08, 2026
Characteristics, treatment and survival of older patients with metastatic triple negative breast cancer from the ESME mBC real-world national cohort: a comparison with younger women.
Journal: Breast (Edinburgh, Scotland)
Published: February 17, 2026
Innovative Research Organization to Facilitate Clinical Trials Implementation in the Era of Molecular Oncology: The Spiderweb Model of the Oncodistinct Network.
Journal: JCO precision oncology
Published: January 21, 2026
Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.
Journal: Cancer communications (London, England)
Published: November 23, 2025
Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 20, 2025
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.
Journal: ESMO open
Published: November 04, 2025
The plasma nanoDSF denaturation profiles predict the presence of breast cancer.
Journal: Journal of translational medicine
Published: September 26, 2025
Multi-omics profiling uncovers immune-molecular clusters with distinct chemo-immunotherapeutic vulnerabilities in a mouse model of triple-negative breast cancer.
Journal: Molecular cancer
Published: September 24, 2025
Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 12, 2025
Phase Ib study of xentuzumab and abemaciclib in patients with advanced solid tumors and in combination with endocrine therapy in patients with advanced breast cancer.
Journal: ESMO open
Published: June 02, 2025
Impact of stereotactic body radiation therapy on systemic therapeutic line change in oligometastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: May 21, 2025
Last Updated: 09/26/2026